JPWO2020053811A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020053811A5
JPWO2020053811A5 JP2021514019A JP2021514019A JPWO2020053811A5 JP WO2020053811 A5 JPWO2020053811 A5 JP WO2020053811A5 JP 2021514019 A JP2021514019 A JP 2021514019A JP 2021514019 A JP2021514019 A JP 2021514019A JP WO2020053811 A5 JPWO2020053811 A5 JP WO2020053811A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
hydrogen
methyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514019A
Other languages
English (en)
Japanese (ja)
Other versions
JP7361766B2 (ja
JP2022500425A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/057710 external-priority patent/WO2020053811A1/fr
Publication of JP2022500425A publication Critical patent/JP2022500425A/ja
Publication of JPWO2020053811A5 publication Critical patent/JPWO2020053811A5/ja
Application granted granted Critical
Publication of JP7361766B2 publication Critical patent/JP7361766B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514019A 2018-09-14 2019-09-12 ヒト免疫不全ウイルス複製の阻害剤 Active JP7361766B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862731196P 2018-09-14 2018-09-14
US62/731,196 2018-09-14
US201862733259P 2018-09-19 2018-09-19
US62/733,259 2018-09-19
PCT/IB2019/057710 WO2020053811A1 (fr) 2018-09-14 2019-09-12 Inhibiteurs de la réplication du virus de l'immunodéficience humaine

Publications (3)

Publication Number Publication Date
JP2022500425A JP2022500425A (ja) 2022-01-04
JPWO2020053811A5 true JPWO2020053811A5 (fr) 2022-08-09
JP7361766B2 JP7361766B2 (ja) 2023-10-16

Family

ID=68240777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514019A Active JP7361766B2 (ja) 2018-09-14 2019-09-12 ヒト免疫不全ウイルス複製の阻害剤

Country Status (4)

Country Link
US (1) US20220089598A1 (fr)
EP (1) EP3849982A1 (fr)
JP (1) JP7361766B2 (fr)
WO (1) WO2020053811A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7398448B2 (ja) 2018-10-24 2023-12-14 ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド ヒト免疫不全ウイルス複製の阻害剤
UA128041C2 (uk) 2019-01-25 2024-03-20 Браун Юніверсіті Спосіб лікування пов'язаного з віком запалення у пацієнта
JPWO2021107066A1 (fr) 2019-11-28 2021-06-03

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102464654B (zh) 2010-11-12 2016-01-13 上海泓博智源医药技术有限公司 抗病毒化合物
PT2729448E (pt) 2011-07-06 2015-12-02 Gilead Sciences Inc Compostos para o tratamento de vih
CN102863512B (zh) 2011-07-07 2016-04-20 上海泓博智源医药技术有限公司 抗病毒化合物
TW201443037A (zh) 2013-01-09 2014-11-16 Gilead Sciences Inc 治療用化合物
AU2014205317B2 (en) 2013-01-09 2016-11-24 Gilead Sciences, Inc. 5-membered heteroaryls and their use as antiviral agents
ES2642265T3 (es) 2013-01-09 2017-11-16 Gilead Sciences, Inc. Compuestos terapéuticos para el tratamiento de infecciones virales
TWI694071B (zh) 2013-03-01 2020-05-21 美商基利科學股份有限公司 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
WO2015130966A1 (fr) 2014-02-28 2015-09-03 Gilead Sciences, Inc. Agents antiviraux
US10202353B2 (en) 2014-02-28 2019-02-12 Gilead Sciences, Inc. Therapeutic compounds
WO2016033243A1 (fr) 2014-08-29 2016-03-03 Gilead Sciences, Inc. Agents antirétroviraux
CN109890808B (zh) 2016-08-19 2020-08-07 吉利德科学公司 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物
TW201906834A (zh) 2017-05-02 2019-02-16 英商Viiv醫療保健英國(No.5)有限公司 人類免疫不全病毒複製之抑制劑
JP7083398B2 (ja) 2018-02-15 2022-06-10 ギリアード サイエンシーズ， インコーポレイテッド ピリジン誘導体およびｈｉｖ感染を処置するためのその使用
CA3175384A1 (fr) 2018-02-16 2019-08-22 Gilead Sciences, Inc. Methodes et intermediaires pour preparer des composes therapeutiques utiles dans le traitement d'une infection virale des retroviridae
ES2962736T3 (es) 2018-04-11 2024-05-24 Viiv Healthcare Uk No 5 Ltd Compuestos de 4-oxo-3,4-dihidroquinazolina como inhibidores de la replicación del virus de la inmunodeficiencia humana
BR112021001617A2 (pt) 2018-08-09 2021-04-27 VIIV Healthcare UK (No.5) Limited inibidores de replicação do vírus da imunodeficiência humana

Similar Documents

Publication Publication Date Title
CA3103522C (fr) Inhibiteurs de capsides pour le traitement du vih
JP2020023528A5 (fr)
JP2019094345A5 (fr)
JP2019509276A5 (fr)
JP2020507589A5 (fr)
JP2018535963A5 (fr)
JP2018524339A5 (fr)
JP2016518437A5 (fr)
JP2016527217A5 (fr)
JP2014037426A5 (fr)
JP2020534263A5 (fr)
JP2016518434A5 (fr)
JP2019518050A5 (fr)
JP2009506119A5 (fr)
JP2015516000A5 (fr)
JP2005538099A5 (fr)
JP2019501879A5 (fr)
JP2022141835A5 (fr)
JP2020512337A5 (fr)
JP2019520344A5 (fr)
JP2020533352A5 (fr)
JP2018529714A (ja) Ｈｉｖの処置のための化合物および組合せ物
JP2019502686A5 (fr)
JP2022536623A (ja) 肺動脈性肺高血圧症の治療方法
JP2016536362A5 (fr)